MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

about

Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.

P2860

Q55515016-405E2759-8C9B-4123-90F6-0B6F8BCB9032

P2860

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

Item

http://www.wikidata.org/entity/Q49275839

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@en

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@nl

type

Item

label

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@en

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@nl

prefLabel

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@en

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@nl

P1476

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

@en

P2093

Hong Pan

http://www.w3.org/2001/XMLSchema#string

Hua Chen

http://www.w3.org/2001/XMLSchema#string

Wenbin Zhou

http://www.w3.org/2001/XMLSchema#string

Xiaoan Liu

http://www.w3.org/2001/XMLSchema#string

Yi Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium

Global cancer statistics, 2012

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

The mammalian anti-proliferative BTG/Tob protein family

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

Triple-Negative Breast Cancer

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

Targeting microRNAs in cancer: rationale, strategies and challenges.

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma

P2888

s12943-017-0754-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12943-017-0754-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100258756

http://www.w3.org/2001/XMLSchema#string

P698

29310680

http://www.w3.org/2001/XMLSchema#string

P932

5759260

http://www.w3.org/2001/XMLSchema#string

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

about

P2860

P2860

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932